| Trial ID: | L0877 |
| Source ID: | JPRN-UMIN000017266
|
| Associated Drug: |
Digestive enzyme
|
| Title: |
A phase II randomized controlled trial on effect of digestive enzymes for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Patients who need pancreaticoduodenectomy
|
| Interventions: |
Control group: Oral administration of conventional digestive enzyme (common dosage) after pancreraticoduodenectomy<br>Test group: Oral administration of high potent digestive enzyme (common dosage) after pancreaticoduodenectomy
|
| Outcome Measures: |
The incidence of non alcoholic fatty liver disease one year after surgeryThe nutritional status, pancreatic endocrine and exocrine function one year after surgery
|
| Sponsor/Collaborators: |
National Defense Medical College
|
| Gender: |
All
|
| Age: |
20years-oldNot applicable
|
| Phases: |
Phase 2
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Parallel Randomized
|
| Start Date: |
24/04/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020030
|
